ARCHIVES

FDA Simplifies Reporting Of Adverse Events

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

March 30, 2012

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

What Is and Isn’t a Crime in Texas: CPRIT Official Indicted For Skipping Peer Review

December 13, 2013

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

Senate Voices Discontent With NIH, NCI Budget; Gorton Presses Raub On Cancer’s ‘Low Priority’

March 22, 1991

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987